SCHEMBL30882575

SCHEMBL30882575

CCOC(=O)C(F)(F)c1cc(C(=O)OC)ccc1F

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NOTUM Q6P988 2/20 0.46
KDM4E B2RXH2 2/20 0.40
CA12 O43570 2/20 0.40
CA1 P00915 2/20 0.40
CA2 P00918 2/20 0.40
CA7 P43166 2/20 0.40
CA9 Q16790 2/20 0.40
CA14 Q9ULX7 2/20 0.40
ALDH1A1 P00352 2/20 0.40
HSD17B2 P37059 1/20 0.40
XDH P47989 1/20 0.40
TDP1 Q9NUW8 1/20 0.39
TTR P02766 1/20 0.39
HDAC3 O15379 1/20 0.39
HDAC1 Q13547 1/20 0.39
HDAC2 Q92769 1/20 0.39
HDAC8 Q9BY41 1/20 0.39
HDAC6 Q9UBN7 1/20 0.39
MEN1 O00255 3/20 0.39
KMT2A Q03164 3/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30882506 1.00 NOTUM (0.46) NOTUMKDM4ECA12CA1CA2
SCHEMBL29723291 0.86 L3MBTL1 (0.45) ALDH1A1MAPTTSHR
SCHEMBL23412483 0.86 L3MBTL1 (0.45) ALDH1A1MAPTTSHR
SCHEMBL30882499 0.83 NOTUM (0.66) NOTUMKDM4ECA12CA1CA2
SCHEMBL31306436 0.81 MAPT (0.43) ALDH1A1MEN1KMT2AMAPTTSHR
SCHEMBL752590 0.79 NOTUM (0.64) NOTUMKDM4ECA12CA1CA2
SCHEMBL14012580 0.79 NOTUM (0.64) NOTUMKDM4ECA12CA1CA2
SCHEMBL29723251 0.79 LMNA (0.43) ALDH1A1MEN1KMT2AMAPT
SCHEMBL23411878 0.79 LMNA (0.43) ALDH1A1MEN1KMT2AMAPT
SCHEMBL2543756 0.79 CA12 (0.53) NOTUMKDM4ECA12CA1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117903077-B Dihydrooxadiazinone compound and application thereof 上海超阳药业有限公司 2024-09-03 CN disclosed
CN-117903077-A Dihydrooxadiazinon compound and application thereof 上海超阳药业有限公司 2024-04-19 CN disclosed